Copyright West LLC. Minimum 15 minutes delayed.

Investors & Media

Events & Presentations

Recent Events

There are currently no events to display.

Archived Events

Date Event Details
Summary Toggle Sep 9, 2019 8:45 AM EDT

H.C. Wainwright 21st Annual Global Investment Conference
Summary Toggle Aug 8, 2019 4:30 PM EDT

Q2 2019 Earnings Conference Call
Summary Toggle Jun 21, 2019

OHF International Workshop Data Poster – June 2019
Summary Toggle Jun 4, 2019 4:00 PM EDT

Jefferies 2019 Healthcare Conference
Summary Toggle May 9, 2019 4:30 PM EDT

Q1 2019 Earnings Conferene Call
Summary Toggle Apr 8, 2019 1:50 PM BST

H.C. Wainwright Global Life Sciences Conference

Summary Toggle Apr 3, 2019

Dicerna Pharmaceuticals Corporate Overview
Summary Toggle Mar 29, 2019

PHYOX ™: A Safety and Tolerability Study of DCR-PHXC in Primary Hyperoxaluria Types 1 and 2
Summary Toggle Mar 12, 2019 8:00 AM EDT

Cowen and Company 39th Annual Healthcare Conference
Summary Toggle Mar 11, 2019 4:30 PM EDT

Q4 2018 Earnings Conference Call
Summary Toggle Mar 1, 2019 9:00 AM EST

8th Annual SVB Leerink Global Healthcare Conference
Summary Toggle Nov 27, 2018 2:45 PM EST

Evercore ISI HealthCONx
Summary Toggle Nov 14, 2018 4:40 PM GMT

Jefferies 2018 London Healthcare Conference
Summary Toggle Nov 13, 2018 11:00 AM EST

Stifel 2018 Healthcare Conference
Summary Toggle Nov 9, 2018 8:00 AM EST

2018 R&D Day
Summary Toggle Nov 9, 2018

Dicerna HBV AASLD Poster 2018
Summary Toggle Nov 5, 2018 4:30 PM EST

Q3 2018 Earnings Conference Call
Summary Toggle Oct 25, 2018

Dicerna PHYOX ASN Poster 2018
Summary Toggle Oct 2, 2018 2:30 PM EDT

LEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology

Summary Toggle Oct 1, 2018 7:45 AM EDT

Cantor Fitzgerald Global Healthcare Conference

Summary Toggle Sep 5, 2018 1:45 PM EDT

HC Wainwright 20th Annual Global Investment Conference
Summary Toggle Aug 8, 2018 4:30 PM EDT

Q2 2018 Earnings Conference Call
Summary Toggle May 14, 2018 4:30 PM EDT

Q1 2018 Earnings Conference Call
Summary Toggle Mar 8, 2018 4:30 PM EST

Q4 2017 Earnings Conference Call
Summary Toggle Oct 26, 2017

GalXC RNAi Platform Enables Potent and Durable RNAi-Mediated Inhibition of Hepatitis B Virus in Preclinical Models
Summary Toggle Aug 15, 2017

Webinar: Dicerna Research Highlights from 12th International Workshop on Primary Hyperoxaluria

Let us know what you thought of the webinar by taking the brief survey

 

This event can be viewed in the following languages:
Summary Toggle Jul 15, 2017

DCR-PHXC:A new approach for treating all Primary Hyperoxalurias by inhibiting LDHA
Summary Toggle Jul 14, 2017

Oxalate Production in Primary Hyperoxaluria Types 1, 2 and 3 and the Role of LDH in the Liver
Summary Toggle Jul 14, 2017

PHYOS: An Observational Study of Patients with Primary Hyperoxaluria Type 1
Summary Toggle May 15, 2017

Dicerna US Tides May 2017 Presentation
Summary Toggle Apr 17, 2017

GalXC cGMP Manufacturing Experience Presentation
Summary Toggle Feb 26, 2017

Asia Tides 2017 Presentation - GalXC Research Update
Summary Toggle Jun 29, 2016 8:30 AM EDT

Dicerna Investor Day 2016